OZTURK, SavasOZKAN, OktayEFE, MuratYazici, HalilGursu, MELTEMKaya, Ali HakanCEBECI, EgemenSUMNU, AbdullahKARADAG, SerhatPOTUROGLU, SuleKazancioglu, RÜMEYZA2019-10-052019-10-052016-04-01OZTURK S., OZKAN O., EFE M., Yazici H., Gursu M., Kaya A. H. , CEBECI E., SUMNU A., KARADAG S., POTUROGLU S., et al., -The relationship between FGF-23 and ghrelin levels in CKD patients: preliminary data-, MINERVA UROLOGICA E NEFROLOGICA, cilt.68, ss.227-232, 2016https://hdl.handle.net/20.500.12645/4431BACKGROUND: Fibroblast growth factor (FGF)-23 is a recently discovered phosphaturic hormone that increases in chronic kidney disease (CKD). It has been accepted as a determinant of mortality and a therapeutic target in these patients. Ghrelin is a hormone that has roles in energy and nutrient metabolism. Ghrelin level was found to be increased in CKD patients. This is a controlled study in which the relationship between FGF-23 and ghrelin levels in CKD patients has been studied.enArticleWOS:00038494510001584992183699